Deals & Cases

07/16/2020

On July 14, 2020, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced the closing of the first tranche of its financing arrangement with a fund managed by Highbridge Capital Management, LLC. The financing makes available up to CHF 20 m in near-term liquidity to Santhera through the issuance of senior secured notes exchangeable into shares of Santhera.


Homburger acted as legal and tax counsel to Santhera. The team was led by partners Dieter Gericke (Corporate | M&A) and Jürg Frick (Banking and Finance) and comprised Stefan Oesterhelt (Tax), counsel Eduard de Zordi (Banking and Finance), associates Daniel Häusermann (Corporate | M&A), David Borer, Alessandra Mengotti and Pierina Janett-Seiler (all Banking and Finance), junior associates Marisa Di Francesco (Banking and Finance) and Oliver Kneubühl (Corporate | M&A).